144 ·Filed Aug 4, 2026

CDNA

CareDx, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001958244-26-000483
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for subsequent Form 4 filings to confirm actual execution of the sale. The modest size and director status suggest limited market impact, but continued insider distribution could indicate sentiment shift. Compare against next earnings for any correlation.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
CDNA ▲ +3.98% at T+5d
NEUTRAL call ✓ call won +3.98% · α vs SPY +3.63% · entry $45.50 → $47.31
Next anchor: T+20d due 4w ago
Latest observation: T+38 -0.65% FF3 residual α
Entry anchored
Aug 4, 03:59 PM ET
via exchange tick
T+1d
-1.52%
call -1.52% · α -1.36%
$44.81
settled 8w ago
T+5d
+3.98%
call +3.98% · α +3.63%
$47.31
settled 7w ago
T+20d
—
call — · α —
—
due 4w ago
T+60d
—
call — · α —
—
in 26d

Price Chart

Loading chart...

Executive Summary

Director Christine Cournoyer filed a Form 144 notice to sell 16,000 common shares of CareDx with an estimated market value of $753,440. The shares were acquired as RSU compensation in 2025. The proposed sale is small relative to CareDx's $2.5B market cap (0.03%) and represents routine insider diversification.

Key Facts

  • Director Christine Cournoyer intends to sell 16,000 shares via Goldman Sachs.
  • Estimated market value of proposed sale is $753,440.
  • Shares were acquired as RSU compensation on 06/14/2025 (10,570 shares) and 03/07/2025 (5,430 shares).
  • The sale represents less than 0.03% of CareDx's market capitalization.
  • Recent insider activity (30d) shows 3 other sells totaling $2.8M.

Financial Impact

Proposed sale of $753,440 in common stock by a director.

dilutioninsider holdings

Risk Factors

  • Further insider selling could weigh on sentiment.
  • No explicit catalyst tied to the filing—sale may be personal financial planning.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
62% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001958244-26-000483
Document: 0001958244-26-000483-index.html0001958244-26-000483
Document: 0001958244-26-000483.txt0001958244-26-000483
9 reports for CDNA
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +28.28%Apr 16, 2026
Filters
Rows
Reports for CDNA — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$44.81 $47.38▲ +5.74%▲ +4.52%$67.15 (+49.85%)
Aug 4, 2026
8w ago
144
NEUTRAL ★ 2/10
$45.50 $47.31▲ +3.98%▲ +3.63%$67.15 (+47.58%)
Jul 17, 2026
11w ago
Insider Cluster
NEUTRAL ★ 4/10
$39.73 $37.61▼ −5.34%▼ −4.65%$67.15 (+69.02%)
Jun 16, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$23.48 $27.13▲ +15.55%▲ +16.59%$67.15 (+185.99%)
Jun 5, 2026
16w ago
DEFA14A
NEUTRAL ★ 2/10
$21.95 $24.08▲ +9.70%▲ +7.59%$67.15 (+205.92%)
Apr 28, 2026
22w ago
S-3ASR
NEUTRAL ★ 5/10
$20.80 $20.70▼ −0.48%▼ −3.59%$67.15 (+222.84%)
Apr 16, 2026
24w ago
8-K
BULLISH ★ 8/10
$22.42 $20.06▼ −10.53%▼ −11.51%$67.15 (+199.51%)
Feb 25, 2026
31w ago
8-K/A
BULLISH ★ 8/10
$18.46 $19.06▲ +3.25%▲ +4.35%$67.15 (+263.76%)
Feb 24, 2026
31w ago
8-K
BULLISH ★ 7/10
$18.46 $19.06▲ +3.25%▲ +4.35%$67.15 (+263.76%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access